The influence of complete revascularization (CR) compared with incomplete revascularization (ICR) on long-term outcomes was assessed in patients with multivessel coronary heart disease undergoing successful percutaneous coronary intervention (PCI). A retrospective analysis of the clinical data, lesion type and PCI data was carried out in 324 patients with multivessel coronary heart disease (CR group, 99 patients; ICR group, 225 patients). Major adverse cardiac events (MACE) were recorded at follow-up (mean ± SD follow-up interval, 18 ± 7.1 months). There were no significant differences in clinical characteristics between the two groups at follow-up, although the CR group showed a nonsignificant tendency to a higher incidence of non-fatal myocardial infarction, cardiac death, repeated revascularization and MACE compared with the ICR group. In conclusion, the long-term prognosis for ICR was not inferior to that for CR in patients with multivessel coronary heart disease undergoing successful PCI.
Introduction
Methods of coronary artery revascularization in patients with multivessel coronary heart disease include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). At present, although the rate of re-stenosis that requires further coronary revascularization is higher in patients undergoing PCI than in those undergoing CABG, 1,2 clinical trials that have compared the outcome of PCI with that of CABG have shown no significant differences in the rates of cardiac death and myocardial infarction. 1 Previously, CABG but not PCI was able to provide complete coronary revascularization. Progress in PCI techniques HH Yang, Y Chen, CY Gao Complete coronary revascularization after percutaneous coronary intervention and improvement in medical instruments have meant that complete revascularization (CR) can now also be achieved following PCI. In countries other than China, studies on the outcome of CR by PCI and on the long-term follow-up 3 -8 have given varying results. There are, however, relatively few reports on this subject from China. The present study explores the influence of CR compared with incomplete revascularization (ICR) on the long-term outcome of patients with multivessel coronary heart disease who had undergone successful PCI. This is a retrospective analysis of clinical data combined with data on the outcomes of patients with multivessel coronary heart disease. 
Patients and methods

PATIENTS
DEFINITIONS
Clinical lesions were defined as > 50% stenosis of a main coronary artery, or > 70% stenosis of its primary branches. The definition of CR was the treatment of all lesions in the main coronary artery and primary branches. Incomplete coronary revascularization (ICR) was defined as treatment of main culprit lesions but not other clinical lesions.
FOLLOW-UP
Detailed information on major adverse cardiac events (MACE) was recorded in all patients during the follow-up period. Followup visits were conducted for at least 12 months and those patients who were unable or unwilling to attend the clinic were followed up by telephone. MACE were defined as death from any cause, cardiac death, non-fatal myocardial infarction, recurrent angina and the need for repeat coronary revascularization (PCI or CABG).
STATISTICAL ANALYSIS
All statistical analyses were performed using SPSS ® statistical package, version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . Numerical data are presented as rates or ratios. Measurement data are expressed as mean ± SD. Group comparisons were performed using the χ 2 -test or Fisher's exact test. A P-value < 0.05 was considered to be statistically significant.
Results
In total, 324 patients with complete clinical and follow-up data were included in the study, of whom 253 (78.1%) were men and 71 were women (21.9%). The mean ± SD duration of follow-up was 18.0 ± 7.1 months. All patients were between 19 and 85 years of age (mean ± SD 61.82 ± 10.59 years). Of the 324 patients, 195 had hypertension, 62 had diabetes mellitus and 151 were previous or current smokers at the time of PCI. Patient demographics and clinical characteristics, including age, gender, hypertension, diabetes mellitus and smoking before and after PCI, did not differ significantly between the two groups ( Table 1) .
With respect to previous coronary artery disease, 300 (92.6%) patients had acute coronary syndrome, 113 (34.9%) had a history of myocardial infarction and 17 (5.2%) had stable angina. A total of 99 patients were included in the CR group and HH Yang, Y Chen, CY Gao Complete coronary revascularization after percutaneous coronary intervention 255 in the ICR group, based on their lesion definitions. All patients had undergone safe, standard PCI; 102 (31.5%) patients had undergone the procedure through a femoral artery and 222 (68.5%) through a radial artery. Eight patients had undergone only percutaneous transluminal coronary angioplasty (PTCA) and did not receive stent implantation because the coronary artery was too small or had a diffuse lesion, 40 patients received direct stent implantation, and the remaining 276 patients received both PTCA and elective stent implantation; 113 patients received only drug-eluting stents, 150 received only bare metal stents and 53 received both types of stent (Table 2) . Of the 324 patients, 140 (43.2%) received treatment of the left anterior descending artery and/or its branches, 108 (33.3%) received treatment of the right coronary artery and/or its branches and 76 (23.5%) received treatment of the left circumflex artery and/or its branches ( Table 2 ). In 209 (64.5%) cases the lesions were types B2 or C. 
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In three (0.9%) cases they were ostial and in 130 (40.1%) cases they were proximal (Table  3) . A total of 490 stents were implanted into the coronary arteries of the 324 patients. One to six stents were implanted in each patient, the mean number being 1.72 stents/patient. The stents were 2.5 -4.0 mm in diameter and 8 -36 mm in length. The number of stents implanted was significantly higher in the CR group than in the ICR group (P < 0.01; Table 4 ). The two groups did not differ in terms of the vessels treated, the type of PCI, the type and location of lesion, the manner of treatment for the treated vessels, PCI route, diameter of the treated vessel, length of lesion and pressure when releasing the stent during PCI.
The incidence of non-fatal myocardial infarction, cardiac death, subsequent CABG and other MACE tended to be lower in the CR group than in the ICR group, but the differences were not statistically significant ( Table 5 ).
Lesion type and location CR (n = 99) ICR (n = 225)
Type of coronary lesion, n (%) A 7 (7.1) 7 a Measured after a minimum follow-up period of 12 months (mean ± SD 18.0 ± 7.1 months).
No statistically significant between-group differences (P > 0.05).
TABLE 3: Lesion types and locations in patients in multivessel coronary heart disease patients undergoing complete revascularization (CR) or incomplete revascularization (ICR) on percutaneous coronary intervention (PCI) a
Variable CR (n = 99) ICR (n = 225)
Reference diameter of lesion, mean ± SD (mm) 2 
TABLE 4: Technical parameters of percutaneous coronary intervention (PCI) and follow-up interval in multivessel coronary heart disease patients who underwent complete revascularization (CR) or incomplete revascularization (ICR) a
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Discussion
The most important aims of the treatment of coronary heart disease are to eliminate myocardial ischaemia, 3 -5 to improve the quality of life, and to decrease the fatality rate and the incidence of MACE. The most effective therapy is CR, however previously, CR could only be achieved with CABG, whereas now both PCI and CABG can achieve CR.
Several retrospective analyses have demonstrated that CR can decrease the fatality rate in patients with multivessel coronary heart disease and relieve the pain of myocardial ischaemia, and the importance of achieving CR has frequently been suggested; 6 -16 although research has not always been able to provide support for this suggestion. In practice, the authors' clinical experience has been that some patients where only ICR is achieved still have a relatively good prognosis. Thus, whether or not to perform CR in patients with multivessel disease remains a difficult question.
The present study described the basic clinical and long-term follow-up data of 324 patients with multivessel coronary artery disease who had undergone PCI. For economic, technical and other reasons, CR was achieved in 99 of these patients but not in the remaining 225 patients. Among patients who have undergone PCI, it has been reported that 17.8 -66.9% only achieve ICR. 6 -16 The present retrospective analysis of basic clinical data, lesion characteristics and technical indices showed no difference between patients where CR was achieved compared with those where ICR was achieved. The groups were well-matched for baseline characteristics which adds to the credibility of the results. The outcome after a mean follow-up of 18 months showed that the two groups did not reach a statistically significant difference in the incidence of MACE, though rates of non-fatal myocardial infarction, cardiac death, CABG and other MACE tended to be lower in the CR than in the ICR group. Thus, based on the present study, the prognosis following ICR may be regarded as similar to that for CR in patients with multivessel coronary heart disease undergoing successful PCI and is consistent with the results of most countries outside of China. 6 -10 For example, Srinivas et al. 6 analysed data on patients with multivessel No statistically significant between-group differences (P > 0.05). CABG, coronary artery bypass grafting.
TABLE 5: Frequency of major adverse cardiac events in multivessel coronary heart disease patients undergoing complete revascularization (CR) or incomplete revascularization (ICR) on percutaneous coronary intervention (PCI) a
HH Yang, Y Chen, CY Gao Complete coronary revascularization after percutaneous coronary intervention coronary heart disease enrolled in the National Heart, Lung and Blood Institute Dynamic Registry, USA, in which 1456 patients only achieved ICR because of the selection strategy and technical limitations. The incidence of MACE, such as accumulative mortality and repeat PCI and CABG, showed no significant difference in patients who achieved CR compared with those who achieved ICR. Rossi et al. 8 analysed clinical data obtained during hospitalization and after 1-year's follow-up for 165 patients of age > 80 years with multivessel coronary heart disease. CR was achieved in 73 (44%) patients but only ICR was achieved in the remaining 92 (56%). During hospitalization and at the 1-year follow-up there was no significant difference in the incidence rate of MACE between the CR and ICR groups. 8 The research indicating that the prognosis for ICR may be regarded as similar to that for CR in patients with multivessel coronary heart disease undergoing successful PCI supports the view that it is feasible to perform elective target PCI in these patients. Ijsselmuiden et al. 11 found no difference in the incidence of MACE and total medical expenses between 108 patients achieving CR and 111 achieving ICR, and concluded that whether or not to aim for CR in patients with multivessel coronary heart disease should be decided independently for each patient. Views on this subject vary. For example, Palmer et al. 9 analysed data on 151 ST-segment acute coronary syndrome patients with multivessel coronary heart disease of whom only 71 achieved CR. There were no significant differences in mortality and the incidence of myocardial infarction between the two groups, but the chances of angina persisting and of repeat PCI were smaller in the CR group than in the ICR group. They concluded that, whilst both CR or elective target PCI are safe and feasible in patients with multivessel disease, CR should be the strategy of choice as it reduces the chances of persistent angina and repeated PCI. The study of McLellan et al. 10 included a large sample of 1308 patients in which CR had been achieved and 648 patients where ICR was achieved. On the basis of 3 years of follow-up data they concluded that CR decreased the occurrence of CABG and mortality, and were in favour of CR, if possible, in patients with multivessel coronary heart disease.
The definitions of CR and ICR are still disputed. Most researchers take ICR to mean > 50% stenosis of any of the main coronary arteries. McLellan et al. 10 proposed that this figure should be ≥ 75%, with the consequence that the rate of CR was relatively high in their study. Moreover, the duration of follow-up has also differed among studies. In most studies, the mean follow-up has been 12 months, although in the present study the mean follow-up was 18 months and it was up to 3 years in the study by McLellan et al. 10 The longer the follow-up time, the higher the incidence of repeat coronary revascularization.
The present study was a case-control design rather than a randomized trial, its scale was relatively small and there was some potential for selection bias. The results must, therefore, be analysed with care before any conclusions are drawn. The data are, however, a true reflection of the authors' clinical practice and provide a credible summary of their clinical experience.
Based on the results of the present study, long-term prognosis for ICR was not inferior to that for CR in patients with multivessel coronary heart disease undergoing successful PCI.
